retatrutide side effects clinical trials experimental weight-loss drug and concerns A new weight-loss drug called
Description
Aetna added Zepbound to preferred-tier coverage on additional commercial plans for the 2026 plan year, narrowing the prior auth gap between Wegovy and Zepbound
In this study, measurements of DXA revealed that total fat mass percentage and android/ginoid ratio decreased with liraglutide 3.0 mg/day compared with placebo
Anesthesiologists should also discuss the risk of regurgitation and food aspiration with other doctors involved in the surgery and the patient, the group said
Schernthaner G, Lotan C, Baltadzhieva-Trendafilova E, Ceponis J, Clodi M, Ducena K, et al
None of these are likely in the near term
